BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21786469)

  • 1. Medications for Alzheimer's disease. Benefits of currently approved drugs are limited, but research continues.
    Harv Ment Health Lett; 2011 Apr; 27(10):4-5. PubMed ID: 21786469
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy strategies in Alzheimer's disease].
    Lacomblez L
    Rev Prat; 1998 Nov; 48(17):1913-7. PubMed ID: 9854394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison table: drugs for Alzheimer's disease.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):e160-e161. PubMed ID: 28922344
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs for cognitive loss and dementia.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):155-161. PubMed ID: 28922342
    [No Abstract]   [Full Text] [Related]  

  • 5. [Symptomatic therapy of Alzheimer dementia].
    Förstl H
    Wien Med Wochenschr; 2002; 152(3-4):77-80. PubMed ID: 11925776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric aspects of phosphodiesterases: An overview.
    Murthy VS; Mangot AG
    Indian J Pharmacol; 2015; 47(6):594-9. PubMed ID: 26729948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pregnancy and psychiatric disorders].
    Szász A; Kovács Z
    Ideggyogy Sz; 2002 Jan; 55(1-2):50-3. PubMed ID: 12122945
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches.
    Hake AM
    Semin Neurol; 2002 Mar; 22(1):71-4. PubMed ID: 12170395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fourth psychoactive drug usage guide.
    Appleton WS
    J Clin Psychiatry; 1982 Jan; 43(1):12-27. PubMed ID: 6119310
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1994 Oct; 36(933):89-96. PubMed ID: 7935156
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1991 May; 33(844):43-50. PubMed ID: 1674103
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psychotropic drugs].
    Müller-Spahn F
    Ther Umsch; 1999 Dec; 56(12):719-25. PubMed ID: 10638279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of the psychological and behavioural disorders of Alzheimer's disease].
    Pancrazi MP; Metais P
    Presse Med; 2005 May; 34(9):667-72. PubMed ID: 15988346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic therapies in geriatric psychiatry.
    Blake LM
    Psychiatr Med; 1991; 9(2):263-73. PubMed ID: 1677480
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy in Alzheimer disease].
    Kovács T
    Orv Hetil; 2004 Apr; 145(17):925-8. PubMed ID: 15170971
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescribing drugs for Alzheimer's disease in primary care: managing cognitive symptoms.
    Drug Ther Bull; 2014 Jun; 52(6):69-72. PubMed ID: 24924683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
    Fariello RG
    Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984
    [No Abstract]   [Full Text] [Related]  

  • 18. How the FDA forgot the evidence: the case of donepezil 23 mg.
    Schwartz LM; Woloshin S
    BMJ; 2012 Mar; 344():e1086. PubMed ID: 22442352
    [No Abstract]   [Full Text] [Related]  

  • 19. Galantamine for Alzheimer's disease and mild cognitive impairment.
    Cusi C; Cantisani TA; Celani MG; Incorvaia B; Righetti E; Candelise L;
    Neuroepidemiology; 2007; 28(2):116-7. PubMed ID: 17409773
    [No Abstract]   [Full Text] [Related]  

  • 20. Alzheimer's disease: clinical treatment options.
    Reichman WE
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1125-32; discussion S1133-8. PubMed ID: 11142177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.